Stock Track | PROCEPT BioRobotics Plunges 6.90% After Q4 Revenue Miss, Broker Downgrades and Fraud Probe

Stock Track02-27

PROCEPT BioRobotics (PRCT) stock experienced a significant 24-hour plunge of 6.90% during Thursday's trading session, reflecting heavy selling pressure.

The sharp decline follows the company's reported wider fourth-quarter net loss and revenue that fell short of analyst expectations. The disappointing financial results prompted immediate reactions from Wall Street, with BofA Securities downgrading the stock to underperform from neutral and Oppenheimer cutting its rating to Perform from Outperform while removing its $60 price target.

Adding to the negative sentiment, law firm Ademi LLP announced it is investigating potential securities fraud claims against the company. The probe focuses on whether Procept made inaccurate statements regarding its financial reporting, business operations, and sales practices for disposable handpieces used with its aquablation technology.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1193190391?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 09:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1193190391","market":"us","top_or_hot":-1,"title":"Stock Track | PROCEPT BioRobotics Plunges 6.90% After Q4 Revenue Miss, Broker Downgrades and Fraud Probe","media":"Stock Track","content":"<p>PROCEPT BioRobotics (PRCT) stock experienced a significant 24-hour plunge of 6.90% during Thursday's trading session, reflecting heavy selling pressure.</p><p>The sharp decline follows the company's reported wider fourth-quarter net loss and revenue that fell short of analyst expectations. The disappointing financial results prompted immediate reactions from Wall Street, with BofA Securities downgrading the stock to underperform from neutral and Oppenheimer cutting its rating to Perform from Outperform while removing its $60 price target.</p><p>Adding to the negative sentiment, law firm Ademi LLP announced it is investigating potential securities fraud claims against the company. The probe focuses on whether Procept made inaccurate statements regarding its financial reporting, business operations, and sales practices for disposable handpieces used with its aquablation technology.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | PROCEPT BioRobotics Plunges 6.90% After Q4 Revenue Miss, Broker Downgrades and Fraud Probe</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | PROCEPT BioRobotics Plunges 6.90% After Q4 Revenue Miss, Broker Downgrades and Fraud Probe\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-27 09:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PROCEPT BioRobotics (PRCT) stock experienced a significant 24-hour plunge of 6.90% during Thursday's trading session, reflecting heavy selling pressure.</p><p>The sharp decline follows the company's reported wider fourth-quarter net loss and revenue that fell short of analyst expectations. The disappointing financial results prompted immediate reactions from Wall Street, with BofA Securities downgrading the stock to underperform from neutral and Oppenheimer cutting its rating to Perform from Outperform while removing its $60 price target.</p><p>Adding to the negative sentiment, law firm Ademi LLP announced it is investigating potential securities fraud claims against the company. The probe focuses on whether Procept made inaccurate statements regarding its financial reporting, business operations, and sales practices for disposable handpieces used with its aquablation technology.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRCT","symbol_name":"PROCEPT BioRobotics","start_time":0,"source_url":"","article_id":"1193190391","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1193190391","pubTimestamp":1772154939,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"PROCEPT BioRobotics (PRCT) stock experienced a significant 24-hour plunge of 6.90% during Thursday's trading session, reflecting heavy selling pressure.The sharp decline follows the company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PRCT":"PROCEPT BioRobotics"},"translate_title":"个股追踪|PROCEPT BioRobotics在Q4营收未达预期、券商下调评级和欺诈调查后暴跌6.90%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRCT":1},"content_text":"PROCEPT BioRobotics (PRCT) stock experienced a significant 24-hour plunge of 6.90% during Thursday's trading session, reflecting heavy selling pressure.The sharp decline follows the company's reported wider fourth-quarter net loss and revenue that fell short of analyst expectations. The disappointing financial results prompted immediate reactions from Wall Street, with BofA Securities downgrading the stock to underperform from neutral and Oppenheimer cutting its rating to Perform from Outperform while removing its $60 price target.Adding to the negative sentiment, law firm Ademi LLP announced it is investigating potential securities fraud claims against the company. The probe focuses on whether Procept made inaccurate statements regarding its financial reporting, business operations, and sales practices for disposable handpieces used with its aquablation technology.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1193190391","isCrawlerRequest":true}